Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CarraShield Labs is a biotechnology and consumer health company focused on developing personal lubricants and protective gels utilizing carrageenan, a natural extract derived from red sea algae. The company's flagship product, Divine 9, is a water-based personal lubricant approved as a Class II medical device that provides natural moisturization and skin-on-skin sensation. Beyond its use as a lubricant, Divine 9 has been evaluated in clinical trials, including the Phase IIB CATCH trial, for its potential to inhibit human papillomavirus (HPV) transmission and prevent HPV-related infections. CarraShield Labs collaborates with academic institutions like McGill University to study the efficacy of its carrageenan-based formulations in sexual health and infection prevention.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CarraShield Labs.